Drugging the undruggable. The Melbourne biotech taking on the world
After finding a molecule that could attack an intractable cancer protein, Ternarx has turned its sights on a harder, and potentially more profitable, target. For most of modern medicine, the basic job of a drug has been simple: find the protein causing the problem and block it. But New Scientist declared in May that we’ll […]